SNTI
Senti Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.33
−2.49%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.21
- Revenue estimate
- $15.9K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.41
- EPS estimate
- -$0.33
- Revenue actual
- $17.0K
- Revenue estimate
- $17.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -15.7%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026